Fat-Specific Sirt6 Ablation Sensitizes Mice to High-Fat Diet–Induced Obesity and Insulin Resistance by Inhibiting Lipolysis
Sirt6 is an NAD+-dependent deacetylase that is involved in the control of energy metabolism. However, the tissue-specific function of Sirt6 in the adipose tissue remains unknown. In this study, we showed that fat-specific Sirt6 knockout (FKO) sensitized mice to high-fat diet–induced obesity, which w...
Saved in:
Published in | Diabetes (New York, N.Y.) Vol. 66; no. 5; pp. 1159 - 1171 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Diabetes Association
01.05.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Sirt6 is an NAD+-dependent deacetylase that is involved in the control of energy metabolism. However, the tissue-specific function of Sirt6 in the adipose tissue remains unknown. In this study, we showed that fat-specific Sirt6 knockout (FKO) sensitized mice to high-fat diet–induced obesity, which was attributed to adipocyte hypertrophy rather than adipocyte hyperplasia. The adipocyte hypertrophy in FKO mice likely resulted from compromised lipolytic activity as an outcome of decreased expression of adipose triglyceride lipase (ATGL), a key lipolytic enzyme. The suppression of ATGL in FKO mice was accounted for by the increased phosphorylation and acetylation of FoxO1, which compromises the transcriptional activity of this positive regulator of ATGL. Fat-specific Sirt6 KO also increased inflammation in the adipose tissue, which may have contributed to insulin resistance in high-fat diet–fed FKO mice. We also observed that in obese patients, the expression of Sirt6 expression is reduced, which is associated with a reduction of ATGL expression. Our results suggest Sirt6 as an attractive therapeutic target for treating obesity and obesity-related metabolic disorders. |
---|---|
AbstractList | Sirt6 is an NAD
-dependent deacetylase that is involved in the control of energy metabolism. However, the tissue-specific function of Sirt6 in the adipose tissue remains unknown. In this study, we showed that fat-specific Sirt6 knockout (FKO) sensitized mice to high-fat diet-induced obesity, which was attributed to adipocyte hypertrophy rather than adipocyte hyperplasia. The adipocyte hypertrophy in FKO mice likely resulted from compromised lipolytic activity as an outcome of decreased expression of adipose triglyceride lipase (ATGL), a key lipolytic enzyme. The suppression of ATGL in FKO mice was accounted for by the increased phosphorylation and acetylation of FoxO1, which compromises the transcriptional activity of this positive regulator of ATGL. Fat-specific Sirt6 KO also increased inflammation in the adipose tissue, which may have contributed to insulin resistance in high-fat diet-fed FKO mice. We also observed that in obese patients, the expression of Sirt6 expression is reduced, which is associated with a reduction of ATGL expression. Our results suggest Sirt6 as an attractive therapeutic target for treating obesity and obesity-related metabolic disorders. Sirt6 is an NAD+-dependent deacetylase that is involved in the control of energy metabolism. However, the tissue-specific function of Sirt6 in the adipose tissue remains unknown. In this study, we showed that fat-specific Sirt6 knockout (FKO) sensitized mice to high-fat diet-induced obesity, which was attributed to adipocyte hypertrophy rather than adipocyte hyperplasia. The adipocyte hypertrophy in FKO mice likely resulted from compromised lipolytic activity as an outcome of decreased expression of adipose triglyceride lipase (ATGL), a key lipolytic enzyme. The suppression of ATGL in FKO mice was accounted for by the increased phosphorylation and acetylation of FoxO1, which compromises the transcriptional activity of this positive regulator of ATGL. Fat-specific Sirt6 KO also increased inflammation in the adipose tissue, which may have contributed to insulin resistance in high-fat diet-fed FKO mice. We also observed that in obese patients, the expression of Sirt6 expression is reduced, which is associated with a reduction of ATGL expression. Our results suggest Sirt6 as an attractive therapeutic target for treating obesity and obesity-related metabolic disorders. |
Author | Xu, Guoheng Zhang, Yuwei Cheng, Shihai Jiang, Wei Chen, Lei Li, Yanping Liu, Qinhui Kuang, Jiangying Zhang, Zhiyong Li, Hong Xie, Wen He, Jinhan Pu, Shiyun Shen, Jing Li, Rui Wu, Tong Qu, Aijuan Zou, Min |
Author_xml | – sequence: 1 givenname: Jiangying surname: Kuang fullname: Kuang, Jiangying organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China – sequence: 2 givenname: Yuwei surname: Zhang fullname: Zhang, Yuwei organization: Division of Endocrinology and Metabolism, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China – sequence: 3 givenname: Qinhui surname: Liu fullname: Liu, Qinhui organization: Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China – sequence: 4 givenname: Jing surname: Shen fullname: Shen, Jing organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China – sequence: 5 givenname: Shiyun surname: Pu fullname: Pu, Shiyun organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China – sequence: 6 givenname: Shihai surname: Cheng fullname: Cheng, Shihai organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China – sequence: 7 givenname: Lei surname: Chen fullname: Chen, Lei organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China – sequence: 8 givenname: Hong surname: Li fullname: Li, Hong organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China – sequence: 9 givenname: Tong surname: Wu fullname: Wu, Tong organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China – sequence: 10 givenname: Rui surname: Li fullname: Li, Rui organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China – sequence: 11 givenname: Yanping surname: Li fullname: Li, Yanping organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China – sequence: 12 givenname: Min surname: Zou fullname: Zou, Min organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China – sequence: 13 givenname: Zhiyong surname: Zhang fullname: Zhang, Zhiyong organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China – sequence: 14 givenname: Wei surname: Jiang fullname: Jiang, Wei organization: Molecular Medicine Research Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China – sequence: 15 givenname: Guoheng surname: Xu fullname: Xu, Guoheng organization: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University, Beijing, China – sequence: 16 givenname: Aijuan surname: Qu fullname: Qu, Aijuan organization: Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing, China – sequence: 17 givenname: Wen surname: Xie fullname: Xie, Wen organization: Center of Pharmacogenetics, School of Pharmacy, University of Pittsburgh, Pittsburgh, PA – sequence: 18 givenname: Jinhan surname: He fullname: He, Jinhan organization: Department of Pharmacy, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China, Laboratory of Clinical Pharmacy and Adverse Drug Reaction, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28250020$$D View this record in MEDLINE/PubMed |
BookMark | eNptkctKAzEUhoMoWqsLX0ACbnQxmkunmSzFa6EiWAV3Qy5nNDLN1ElmUUHwHXxDn8RUqwuREzjk5Pt_wvk30apvPCC0Q8kh41wcWU2HGWUsX0E9KrnMOBP3q6hHCGUZFVJsoM0Qngghw1TraIMVLCeEkR56PVcxm8zAuMoZPHFtHOJjXavoGo8n4IOL7gUCvnIGcGzwpXt4zJIGnzqIH2_vI287AxZfa0joHCtv8ciHrnYe36RRiMonpZ6n6aPTyc0_4LGbNfU8PW6htUrVAbaXvY_uzs9uTy6z8fXF6OR4nBkuZMxsYa20tLCyygeGKi0HgiiRC6gkE7QAS5XNdW6kMYxXlgtKKRSQbtpUA8P7aP_bd9Y2zx2EWE5dMFDXykPThZIWggtGeM4SuvcHfWq61qfflWm1jKYj80TtLqlOT8GWs9ZNVTsvfxabgINvwLRNCC1Uvwgl5SK0chFauQgtsUd_WOPiVwKxVa7-R_EJ89KaBQ |
CitedBy_id | crossref_primary_10_18632_oncotarget_18550 crossref_primary_10_1002_hep_30062 crossref_primary_10_1021_acsomega_3c04122 crossref_primary_10_1210_endocr_bqad147 crossref_primary_10_3389_fphys_2018_00135 crossref_primary_10_14336_AD_2022_0413 crossref_primary_10_3389_fendo_2018_00687 crossref_primary_10_3390_ijms20061462 crossref_primary_10_3389_fimmu_2024_1448535 crossref_primary_10_1038_s41467_021_23545_7 crossref_primary_10_3389_fphar_2019_00548 crossref_primary_10_1007_s00018_023_05093_z crossref_primary_10_2337_dbi17_0025 crossref_primary_10_1002_jcp_29235 crossref_primary_10_1002_med_21753 crossref_primary_10_2337_db22_0362 crossref_primary_10_1530_JOE_17_0033 crossref_primary_10_1007_s00109_021_02082_2 crossref_primary_10_1007_s10565_022_09735_z crossref_primary_10_3389_fendo_2018_00724 crossref_primary_10_1002_jcb_26046 crossref_primary_10_3389_fendo_2023_1244705 crossref_primary_10_1152_physrev_00030_2018 crossref_primary_10_1007_s11357_022_00713_1 crossref_primary_10_3389_jpps_2024_13080 crossref_primary_10_1016_j_bbadis_2020_165756 crossref_primary_10_1155_2018_6256052 crossref_primary_10_1016_j_ebiom_2018_11_005 crossref_primary_10_3390_biom12081079 crossref_primary_10_1186_s12933_019_0931_0 crossref_primary_10_18632_oncotarget_23259 crossref_primary_10_1016_j_apsb_2019_11_017 crossref_primary_10_1038_s41387_021_00168_x crossref_primary_10_1002_jcsm_13734 crossref_primary_10_1016_j_phrs_2024_107493 crossref_primary_10_1002_iub_2707 crossref_primary_10_1038_s41467_019_10348_0 crossref_primary_10_1186_s12964_024_02025_7 crossref_primary_10_1007_s12272_017_0989_8 crossref_primary_10_3389_fonc_2022_861334 crossref_primary_10_3390_ijms20051153 crossref_primary_10_3390_ijms24119655 crossref_primary_10_3389_fphys_2018_00608 crossref_primary_10_1007_s00018_021_04061_9 crossref_primary_10_1002_jcp_28500 crossref_primary_10_1089_ars_2023_0295 crossref_primary_10_3389_fendo_2023_1286838 crossref_primary_10_2147_DMSO_S250699 crossref_primary_10_1074_jbc_RA118_005309 crossref_primary_10_3390_cells13010048 crossref_primary_10_1038_s42255_022_00644_3 crossref_primary_10_1152_ajpregu_00238_2021 crossref_primary_10_5937_hraIsh2101001M crossref_primary_10_1038_s12276_021_00664_1 crossref_primary_10_1038_s41598_022_09174_0 crossref_primary_10_3389_fendo_2018_00748 crossref_primary_10_1186_s13148_024_01710_1 crossref_primary_10_1016_j_domaniend_2020_106513 crossref_primary_10_1042_CS20230433 crossref_primary_10_1007_s40618_020_01446_8 crossref_primary_10_1016_j_abb_2020_108260 crossref_primary_10_1016_j_lfs_2021_119803 crossref_primary_10_1186_s12979_024_00481_w crossref_primary_10_1038_s12276_019_0256_9 crossref_primary_10_1074_jbc_RA120_014883 crossref_primary_10_1016_j_bbrc_2019_12_111 crossref_primary_10_4093_dmj_2022_0270 crossref_primary_10_1155_2020_7374086 crossref_primary_10_3389_jpps_2024_13062 crossref_primary_10_1007_s10787_019_00663_9 crossref_primary_10_1016_j_celrep_2019_11_067 crossref_primary_10_1016_j_mce_2020_110928 crossref_primary_10_1016_j_molmet_2020_100994 crossref_primary_10_1016_j_lfs_2019_116558 crossref_primary_10_1007_s00592_021_01759_x crossref_primary_10_1080_10408363_2019_1699498 crossref_primary_10_1016_j_biopha_2023_114311 crossref_primary_10_1016_j_ymthe_2019_06_017 crossref_primary_10_1186_s10020_023_00676_9 crossref_primary_10_3390_nu16244424 crossref_primary_10_1096_fj_202002607 crossref_primary_10_1152_ajpendo_00057_2018 crossref_primary_10_3389_fphar_2020_598326 crossref_primary_10_1016_j_bcp_2022_115022 crossref_primary_10_1016_j_fsi_2020_01_029 crossref_primary_10_3390_cells12040663 crossref_primary_10_1007_s12012_024_09858_1 crossref_primary_10_1016_j_jphs_2020_12_008 crossref_primary_10_1002_cbf_3860 crossref_primary_10_1038_s41419_023_05582_w crossref_primary_10_15252_embr_201846377 crossref_primary_10_1074_jbc_REV120_011438 crossref_primary_10_3389_fphys_2021_755060 |
Cites_doi | 10.1016/j.cmet.2005.04.003 10.1016/j.febslet.2008.01.019 10.2337/db12-1039 10.1016/j.cmet.2010.06.009 10.1016/j.molcel.2012.09.030 10.1016/j.cmet.2011.09.012 10.1126/science.1123965 10.1038/ncomms6011 10.1016/j.cmet.2011.02.005 10.1016/j.jhep.2013.07.027 10.1007/s00125-006-0336-y 10.1016/j.cmet.2011.05.002 10.1042/CS20160465 10.1152/ajpendo.00122.2007 10.1016/j.cell.2009.12.041 10.1111/j.1474-9726.2009.00544.x 10.1126/science.1100747 10.1073/pnas.97.2.787 10.1074/jbc.M110.168039 10.1016/j.physbeh.2008.01.002 10.1152/ajpendo.00235.2007 10.1111/bph.13336 10.1016/S0022-2275(20)32429-9 10.1016/j.cell.2008.10.052 10.1038/nature12038 10.1146/annurev.nutr.27.061406.093734 10.1074/jbc.M113.515320 10.1074/jbc.M110.140228 10.1038/nm.3056 10.1016/j.cell.2005.11.044 10.1172/JCI26498 10.1074/jbc.C800241200 10.1016/j.cellsig.2005.08.009 10.1016/j.metabol.2015.02.005 10.1073/pnas.0502738102 10.2337/diabetes.54.11.3190 10.1053/j.gastro.2011.02.055 10.1016/j.cmet.2012.04.001 10.1038/nm.1904 10.1016/j.cmet.2011.12.018 10.1074/jbc.M508414200 10.2337/db08-1644 |
ContentType | Journal Article |
Copyright | 2017 by the American Diabetes Association. Copyright American Diabetes Association May 1, 2017 |
Copyright_xml | – notice: 2017 by the American Diabetes Association. – notice: Copyright American Diabetes Association May 1, 2017 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. NAPCQ 7X8 |
DOI | 10.2337/db16-1225 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Premium MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1939-327X |
EndPage | 1171 |
ExternalDocumentID | 28250020 10_2337_db16_1225 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .55 .XZ 08P 0R~ 18M 29F 2WC 354 4.4 53G 5GY 5RE 5RS 5VS 6PF 8R4 8R5 AAFWJ AAQQT AAWTL AAYEP AAYOK AAYXX ABOCM ACGFO ACGOD ACPRK ADBBV AEGXH AENEX AERZD AHMBA AIAGR AIZAD ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL BES BTFSW CITATION CS3 DIK DU5 E3Z EBS EDB EJD EMOBN EX3 F5P FRP GX1 H13 HZ~ IAO IEA IHR INH INR IOF IPO K2M KQ8 L7B M5~ O5R O5S O9- OHH OK1 OVD P2P PCD Q2X RHI RPM SJN SV3 TDI TEORI TR2 VVN W8F WH7 WOQ WOW X7M YFH YHG YOC ZY1 ~KM .GJ 1CY 3V. 7RV 7X7 88E 88I 8AF 8AO 8C1 8F7 8FE 8FH 8FI 8FJ 8G5 8GL AAKAS AAYJJ ABUWG ADZCM AFFNX AFHIN AFKRA AI. AZQEC BBNVY BCR BCU BEC BENPR BHPHI BKEYQ BKNYI BLC BPHCQ BVXVI C1A CCPQU CGR CUY CVF DWQXO ECM EIF FYUFA GICCO GNUQQ GUQSH HCIFZ HMCUK H~9 IAG ITC J5H K-O K9- LK8 M0R M1P M2O M2P M2Q M7P MVM N4W NAPCQ NPM OB3 PEA PKN PQQKQ PROAC PSQYO RHF S0X SJFOW UKHRP VH1 XOL YQJ ZGI ZXP K9. 7X8 |
ID | FETCH-LOGICAL-c379t-d8dd9d18d9f54c1ab9470a757ef92718ed1ad5b5c9cc23fd37111e8ecc2bcf4c3 |
ISSN | 0012-1797 |
IngestDate | Fri Jul 11 04:59:27 EDT 2025 Fri Jul 25 19:24:58 EDT 2025 Wed Feb 19 02:42:50 EST 2025 Tue Jul 01 03:11:00 EDT 2025 Thu Apr 24 23:11:04 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | 2017 by the American Diabetes Association. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c379t-d8dd9d18d9f54c1ab9470a757ef92718ed1ad5b5c9cc23fd37111e8ecc2bcf4c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 28250020 |
PQID | 1932132195 |
PQPubID | 34443 |
PageCount | 13 |
ParticipantIDs | proquest_miscellaneous_1873720352 proquest_journals_1932132195 pubmed_primary_28250020 crossref_primary_10_2337_db16_1225 crossref_citationtrail_10_2337_db16_1225 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2017-05-01 |
PublicationDateYYYYMMDD | 2017-05-01 |
PublicationDate_xml | – month: 05 year: 2017 text: 2017-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: New York |
PublicationTitle | Diabetes (New York, N.Y.) |
PublicationTitleAlternate | Diabetes |
PublicationYear | 2017 |
Publisher | American Diabetes Association |
Publisher_xml | – name: American Diabetes Association |
References | Zechner (2022031303354640200_B5) 2012; 15 Zhong (2022031303354640200_B42) 2010; 140 Kanfi (2022031303354640200_B17) 2010; 9 Qiang (2022031303354640200_B30) 2010; 285 Festuccia (2022031303354640200_B38) 2006; 49 Langin (2022031303354640200_B3) 2005; 54 Chakrabarti (2022031303354640200_B9) 2009; 284 Pu (2022031303354640200_B26) 2016; 173 Carmen (2022031303354640200_B35) 2006; 18 Glass (2022031303354640200_B40) 2012; 15 Steinberg (2022031303354640200_B39) 2007; 293 Jaworski (2022031303354640200_B25) 2009; 15 Liew (2022031303354640200_B33) 2013; 19 Van Meter (2022031303354640200_B23) 2014; 5 Kanda (2022031303354640200_B43) 2006; 116 Moschen (2022031303354640200_B19) 2013; 59 Duncan (2022031303354640200_B1) 2007; 27 Ahmadian (2022031303354640200_B11) 2011; 13 Matsuzaki (2022031303354640200_B31) 2005; 102 Kawahara (2022031303354640200_B41) 2009; 136 Zimmermann (2022031303354640200_B6) 2004; 306 Jiang (2022031303354640200_B22) 2013; 496 Kanfi (2022031303354640200_B15) 2008; 582 Jocken (2022031303354640200_B36) 2008; 94 Kim (2022031303354640200_B16) 2010; 12 Kurat (2022031303354640200_B8) 2006; 281 Faust (2022031303354640200_B2) 1978; 235 Ahmadian (2022031303354640200_B12) 2009; 58 Kershaw (2022031303354640200_B13) 2007; 293 Xiao (2022031303354640200_B28) 2010; 285 Large (2022031303354640200_B34) 1999; 40 Banks (2022031303354640200_B37) 2011; 14 He (2022031303354640200_B21) 2013; 62 Mostoslavsky (2022031303354640200_B14) 2006; 124 He (2022031303354640200_B24) 2015; 64 Eguchi (2022031303354640200_B29) 2011; 13 Grönke (2022031303354640200_B7) 2005; 1 Kwok (2022031303354640200_B32) 2016; 130 Dominy (2022031303354640200_B18) 2012; 48 He (2022031303354640200_B27) 2011; 140 Haemmerle (2022031303354640200_B10) 2006; 312 Osuga (2022031303354640200_B4) 2000; 97 Nguyen (2022031303354640200_B20) 2014; 289 |
References_xml | – volume: 1 start-page: 323 year: 2005 ident: 2022031303354640200_B7 article-title: Brummer lipase is an evolutionary conserved fat storage regulator in Drosophila publication-title: Cell Metab doi: 10.1016/j.cmet.2005.04.003 – volume: 582 start-page: 543 year: 2008 ident: 2022031303354640200_B15 article-title: Regulation of SIRT6 protein levels by nutrient availability publication-title: FEBS Lett doi: 10.1016/j.febslet.2008.01.019 – volume: 62 start-page: 1876 year: 2013 ident: 2022031303354640200_B21 article-title: PXR ablation alleviates diet-induced and genetic obesity and insulin resistance in mice publication-title: Diabetes doi: 10.2337/db12-1039 – volume: 12 start-page: 224 year: 2010 ident: 2022031303354640200_B16 article-title: Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis publication-title: Cell Metab doi: 10.1016/j.cmet.2010.06.009 – volume: 48 start-page: 900 year: 2012 ident: 2022031303354640200_B18 article-title: The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis publication-title: Mol Cell doi: 10.1016/j.molcel.2012.09.030 – volume: 235 start-page: E279 year: 1978 ident: 2022031303354640200_B2 article-title: Diet-induced adipocyte number increase in adult rats: a new model of obesity publication-title: Am J Physiol – volume: 14 start-page: 587 year: 2011 ident: 2022031303354640200_B37 article-title: Dissociation of the glucose and lipid regulatory functions of FoxO1 by targeted knockin of acetylation-defective alleles in mice publication-title: Cell Metab doi: 10.1016/j.cmet.2011.09.012 – volume: 312 start-page: 734 year: 2006 ident: 2022031303354640200_B10 article-title: Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase publication-title: Science doi: 10.1126/science.1123965 – volume: 5 start-page: 5011 year: 2014 ident: 2022031303354640200_B23 article-title: SIRT6 represses LINE1 retrotransposons by ribosylating KAP1 but this repression fails with stress and age publication-title: Nat Commun doi: 10.1038/ncomms6011 – volume: 13 start-page: 249 year: 2011 ident: 2022031303354640200_B29 article-title: Transcriptional control of adipose lipid handling by IRF4 publication-title: Cell Metab doi: 10.1016/j.cmet.2011.02.005 – volume: 59 start-page: 1315 year: 2013 ident: 2022031303354640200_B19 article-title: Adipose tissue and liver expression of SIRT1, 3, and 6 increase after extensive weight loss in morbid obesity publication-title: J Hepatol doi: 10.1016/j.jhep.2013.07.027 – volume: 49 start-page: 2427 year: 2006 ident: 2022031303354640200_B38 article-title: PPARgamma agonism increases rat adipose tissue lipolysis, expression of glyceride lipases, and the response of lipolysis to hormonal control publication-title: Diabetologia doi: 10.1007/s00125-006-0336-y – volume: 13 start-page: 739 year: 2011 ident: 2022031303354640200_B11 article-title: Desnutrin/ATGL is regulated by AMPK and is required for a brown adipose phenotype publication-title: Cell Metab doi: 10.1016/j.cmet.2011.05.002 – volume: 130 start-page: 2087 year: 2016 ident: 2022031303354640200_B32 article-title: Adipose-specific inactivation of JNK alleviates atherosclerosis in apoE-deficient mice publication-title: Clin Sci (Lond) doi: 10.1042/CS20160465 – volume: 293 start-page: E1736 year: 2007 ident: 2022031303354640200_B13 article-title: PPARgamma regulates adipose triglyceride lipase in adipocytes in vitro and in vivo publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00122.2007 – volume: 140 start-page: 280 year: 2010 ident: 2022031303354640200_B42 article-title: The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha publication-title: Cell doi: 10.1016/j.cell.2009.12.041 – volume: 9 start-page: 162 year: 2010 ident: 2022031303354640200_B17 article-title: SIRT6 protects against pathological damage caused by diet-induced obesity publication-title: Aging Cell doi: 10.1111/j.1474-9726.2009.00544.x – volume: 306 start-page: 1383 year: 2004 ident: 2022031303354640200_B6 article-title: Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase publication-title: Science doi: 10.1126/science.1100747 – volume: 97 start-page: 787 year: 2000 ident: 2022031303354640200_B4 article-title: Targeted disruption of hormone-sensitive lipase results in male sterility and adipocyte hypertrophy, but not in obesity publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.97.2.787 – volume: 285 start-page: 36776 year: 2010 ident: 2022031303354640200_B28 article-title: SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice publication-title: J Biol Chem doi: 10.1074/jbc.M110.168039 – volume: 94 start-page: 219 year: 2008 ident: 2022031303354640200_B36 article-title: Catecholamine-induced lipolysis in adipose tissue and skeletal muscle in obesity publication-title: Physiol Behav doi: 10.1016/j.physbeh.2008.01.002 – volume: 293 start-page: E958 year: 2007 ident: 2022031303354640200_B39 article-title: Adipocyte triglyceride lipase expression in human obesity publication-title: Am J Physiol Endocrinol Metab doi: 10.1152/ajpendo.00235.2007 – volume: 173 start-page: 66 year: 2016 ident: 2022031303354640200_B26 article-title: Loss of 5-lipoxygenase activity protects mice against paracetamol-induced liver toxicity publication-title: Br J Pharmacol doi: 10.1111/bph.13336 – volume: 40 start-page: 2059 year: 1999 ident: 2022031303354640200_B34 article-title: Decreased expression and function of adipocyte hormone-sensitive lipase in subcutaneous fat cells of obese subjects publication-title: J Lipid Res doi: 10.1016/S0022-2275(20)32429-9 – volume: 136 start-page: 62 year: 2009 ident: 2022031303354640200_B41 article-title: SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span publication-title: Cell doi: 10.1016/j.cell.2008.10.052 – volume: 496 start-page: 110 year: 2013 ident: 2022031303354640200_B22 article-title: SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine publication-title: Nature doi: 10.1038/nature12038 – volume: 27 start-page: 79 year: 2007 ident: 2022031303354640200_B1 article-title: Regulation of lipolysis in adipocytes publication-title: Annu Rev Nutr doi: 10.1146/annurev.nutr.27.061406.093734 – volume: 289 start-page: 1688 year: 2014 ident: 2022031303354640200_B20 article-title: Very low density lipoprotein receptor (VLDLR) expression is a determinant factor in adipose tissue inflammation and adipocyte-macrophage interaction publication-title: J Biol Chem doi: 10.1074/jbc.M113.515320 – volume: 285 start-page: 27396 year: 2010 ident: 2022031303354640200_B30 article-title: Uncoupling of acetylation from phosphorylation regulates FoxO1 function independent of its subcellular localization publication-title: J Biol Chem doi: 10.1074/jbc.M110.140228 – volume: 19 start-page: 217 year: 2013 ident: 2022031303354640200_B33 article-title: Ablation of TRIP-Br2, a regulator of fat lipolysis, thermogenesis and oxidative metabolism, prevents diet-induced obesity and insulin resistance publication-title: Nat Med doi: 10.1038/nm.3056 – volume: 124 start-page: 315 year: 2006 ident: 2022031303354640200_B14 article-title: Genomic instability and aging-like phenotype in the absence of mammalian SIRT6 publication-title: Cell doi: 10.1016/j.cell.2005.11.044 – volume: 116 start-page: 1494 year: 2006 ident: 2022031303354640200_B43 article-title: MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity publication-title: J Clin Invest doi: 10.1172/JCI26498 – volume: 284 start-page: 13296 year: 2009 ident: 2022031303354640200_B9 article-title: FoxO1 controls insulin-dependent adipose triglyceride lipase (ATGL) expression and lipolysis in adipocytes publication-title: J Biol Chem doi: 10.1074/jbc.C800241200 – volume: 18 start-page: 401 year: 2006 ident: 2022031303354640200_B35 article-title: Signalling mechanisms regulating lipolysis publication-title: Cell Signal doi: 10.1016/j.cellsig.2005.08.009 – volume: 64 start-page: 826 year: 2015 ident: 2022031303354640200_B24 article-title: Thiazolidinediones attenuate lipolysis and ameliorate dexamethasone-induced insulin resistance publication-title: Metabolism doi: 10.1016/j.metabol.2015.02.005 – volume: 102 start-page: 11278 year: 2005 ident: 2022031303354640200_B31 article-title: Acetylation of Foxo1 alters its DNA-binding ability and sensitivity to phosphorylation publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0502738102 – volume: 54 start-page: 3190 year: 2005 ident: 2022031303354640200_B3 article-title: Adipocyte lipases and defect of lipolysis in human obesity publication-title: Diabetes doi: 10.2337/diabetes.54.11.3190 – volume: 140 start-page: 2095 year: 2011 ident: 2022031303354640200_B27 article-title: PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts publication-title: Gastroenterology doi: 10.1053/j.gastro.2011.02.055 – volume: 15 start-page: 635 year: 2012 ident: 2022031303354640200_B40 article-title: Inflammation and lipid signaling in the etiology of insulin resistance publication-title: Cell Metab doi: 10.1016/j.cmet.2012.04.001 – volume: 15 start-page: 159 year: 2009 ident: 2022031303354640200_B25 article-title: AdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiency publication-title: Nat Med doi: 10.1038/nm.1904 – volume: 15 start-page: 279 year: 2012 ident: 2022031303354640200_B5 article-title: Fat signals--lipases and lipolysis in lipid metabolism and signaling publication-title: Cell Metab doi: 10.1016/j.cmet.2011.12.018 – volume: 281 start-page: 491 year: 2006 ident: 2022031303354640200_B8 article-title: Obese yeast: triglyceride lipolysis is functionally conserved from mammals to yeast publication-title: J Biol Chem doi: 10.1074/jbc.M508414200 – volume: 58 start-page: 855 year: 2009 ident: 2022031303354640200_B12 article-title: Adipose overexpression of desnutrin promotes fatty acid use and attenuates diet-induced obesity publication-title: Diabetes doi: 10.2337/db08-1644 |
SSID | ssj0006060 |
Score | 2.541596 |
Snippet | Sirt6 is an NAD+-dependent deacetylase that is involved in the control of energy metabolism. However, the tissue-specific function of Sirt6 in the adipose... Sirt6 is an NAD -dependent deacetylase that is involved in the control of energy metabolism. However, the tissue-specific function of Sirt6 in the adipose... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 1159 |
SubjectTerms | Ablation Acetylation Adipocytes - metabolism Adipocytes - pathology Adipose tissue Adipose Tissue - metabolism Adipose Tissue, White - metabolism Adipose Tissue, White - pathology Adult Animals Blotting, Western Cell Enlargement Chromatin Immunoprecipitation Diet Diet, High-Fat Energy Energy metabolism Flow Cytometry Forkhead Box Protein O1 - metabolism FOXO1 protein Glucose Tolerance Test High fat diet Humans Hyperplasia Hypertrophy Immunoprecipitation Inflammation Insulin Insulin resistance Insulin Resistance - genetics Lipase Lipase - genetics Lipase - metabolism Lipolysis Lipolysis - genetics Metabolic disorders Metabolism Mice Mice, Knockout Middle Aged NAD Obesity Obesity - genetics Oils & fats Phosphorylation Real-Time Polymerase Chain Reaction Rodents Sirtuins - genetics Transcription |
Title | Fat-Specific Sirt6 Ablation Sensitizes Mice to High-Fat Diet–Induced Obesity and Insulin Resistance by Inhibiting Lipolysis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28250020 https://www.proquest.com/docview/1932132195 https://www.proquest.com/docview/1873720352 |
Volume | 66 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFB7WCuKLeHdtlVF8EEp0k0k2mceillqpoG1hfQpzSxuQbGkTSguC_8E_4e_yl3hO5rLpWqEKS1gmOZPdPV_Obc-FkBcTnWplALzTaWqiVE50xI0uoiKtBNgfZporrB3e-Tjd2k-3Z9lsNPo5yFrqWvlKnV9aV_I_XIU14CtWyf4DZ8OmsADvgb9wBA7D8Uo83hRt1A-Qr2q1vlsft9P1DWmT20AINJiOdW5OMDW-H5CBOR0R0ICcM63PcmA4vAOTANyIAJcgbDPUP8MSmo9AD2bq--awlnVr66KO5n0zk6Fx-3YQx12e8DOIOHzoXIx6G6B5cOZ15zB6_aU7NXXIFao7XPtUN4ddWNz1VSWe3EUuQBuGPEEvjeME26NahWusAOaMRyzJZ0MJbeeyOCRmA3EL5iwfqO44tuNcltVCwvrGAlrGOHPIFlpfbL29pBJDoiK4SEhcImmJpNfI9QQcEubjQk7ngxtoi53cN7I9rJD0dbjrRcvnL-5Mb9bs3Sa3nD9CNyy47pCRae6SGzsu4-Ie-TbEGO0xRj3G6AJjFDFG2zn1GKOIsV_ffzh0UYcuCuiiDl10gS4qz-gCXTSg6z7Z33y392YrciM7IsVy3ka60JrruNC8ylIVC8nTfCLyLDcVT8AMMjoWOpOZ4kolrNIsB11rCpAjiVRVqtgDstLMG_OIUAGmlWSwX8FT2KTimRC9CpIgVTgXY_LS_5ylcv3scazK1_IPpo3J83DpkW3ictlFa54npXvGT0p0b2J4cTj9LJwGCYx_q4nGzDu4puhHPYEnMyYPLS_DXbAyHD2yx1f5BKvk5uIxWSMr7XFnnoDJ28qnPdp-AxM7q9A |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Fat-Specific+Sirt6+Ablation+Sensitizes+Mice+to+High-Fat+Diet%E2%80%93Induced+Obesity+and+Insulin+Resistance+by+Inhibiting+Lipolysis&rft.jtitle=Diabetes+%28New+York%2C+N.Y.%29&rft.au=Kuang%2C+Jiangying&rft.au=Zhang%2C+Yuwei&rft.au=Liu%2C+Qinhui&rft.au=Shen%2C+Jing&rft.date=2017-05-01&rft.issn=0012-1797&rft.eissn=1939-327X&rft.volume=66&rft.issue=5&rft.spage=1159&rft.epage=1171&rft_id=info:doi/10.2337%2Fdb16-1225&rft.externalDBID=n%2Fa&rft.externalDocID=10_2337_db16_1225 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0012-1797&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0012-1797&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0012-1797&client=summon |